CAT
70
-9
NAVI
35
-5
NEE
52
-2
UHS
60
-3
CL
59
3
ILMN
70
-4
AME
65
-6
CNP
52
2
NFLX
37
2
STZ
55
-2
PCG
66
5
EL
56
4
VZ
45
6
DHR
66
-4
HPE
64
-5
RF
74
-2
VMC
57
-3
IRM
46
-11
DOW
43
-5
AN
52
-13
CAT
70
-9
NAVI
35
-5
NEE
52
-2
UHS
60
-3
CL
59
3
ILMN
70
-4
AME
65
-6
CNP
52
2
NFLX
37
2
STZ
55
-2
PCG
66
5
EL
56
4
VZ
45
6
DHR
66
-4
HPE
64
-5
RF
74
-2
VMC
57
-3
IRM
46
-11
DOW
43
-5
AN
52
-13
Financhill
Back

Dorman Products, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
40

DORM
Dorman Products, Inc.

Last Price:
$128.06
Seasonality Move:
2.36%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Sell
40
Dorman Products, Inc. (DORM) is a Sell

Is Dorman Products, Inc. a Buy, Sell or Hold?

  • The current Dorman Products, Inc. [DORM] share price is $128.01. The Score for DORM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • DORM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DORM Stock Price Chart

What is Dorman Products, Inc.'s stock price today?

  • The Dorman Products, Inc. share price today is $128.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DORM is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

DORM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.85 Sell
Relative Strength Index (14 RSI): 43.92 Sell
Chaikin Money Flow: -71395 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (126.61 - 133.87) Sell
Bollinger Bands (100): (129.49 - 157.11) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

DORM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.57 Buy
20-day SMA: 129.09 Sell
50-day SMA: 136.33 Sell
200-day SMA: 133.18 Sell
8-day EMA: 127.38 Buy
20-day EMA: 129.56 Sell
50-day EMA: 135.07 Sell
200-day EMA: 133.95 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Dorman Products, Inc. Earnings Growth & DORM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and an increase next year of $0.63 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Dorman Products, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):